Remote Opioid Dose Approval With Biometric Patient Verification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

It is difficult to provide opioid treatment medication, such as methadone, to underserved and remote areas due to the requirement for authorized officials to physically diagnose and prescribe, and telemedicine services lacking proper certifications.

Innovation Solution

A method and system for remotely approving and dispensing opioid addiction treatment using biometric sensing, remote communication with certified medical officials, and generating event records for direct patient dosing, incorporating a computing system with communication, processor, and memory components to manage patient identity and medical records.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If authorized officials physically diagnose and prescribe opioid treatment drugs, then proper medical oversight and certification are ensured, but patients in remote areas must travel long distances

Engineering Contradiction:
Improvemedical oversight qualityVSAvoidtravel distance
Core Design Contradiction:
ReliabilityVSLength of moving object

Solution Approach 1:

The patent introduces a telemedicine platform as an intermediary between authorized medical officials and patients. This platform enables remote video consultations, allowing officials to provide medical oversight and prescriptions without patients needing to travel physically. The intermediary technology bridges the gap between the need for certified medical supervision and the accessibility challenge in remote areas.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces the mechanical requirement of physical presence with electronic communication systems. Video conferencing, digital record-keeping, and electronic prescribing systems substitute for in-person interactions, maintaining the reliability of medical oversight while eliminating the need for patient travel to remote clinics.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Length of moving object

If telemedicine services are used for opioid treatment, then patient travel is reduced, but proper certifications for prescribing opioid treatment drugs are lacking

Engineering Contradiction:
Improvetravel distanceVSAvoidcertification authorization
Core Design Contradiction:
Length of moving objectVSReliability

Solution Approach 1:

The patent implements preliminary verification of medical official certifications before allowing telemedicine consultations for opioid treatment. The system pre-authenticates the credentials and licensing of medical professionals, ensuring they have proper authorization to prescribe opioid treatment drugs remotely. This preliminary action establishes trust and compliance before the actual treatment begins.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent incorporates feedback mechanisms where the telemedicine system continuously verifies and monitors the certification status of medical officials. The system provides real-time feedback on authorization validity, ensuring that only properly certified providers can conduct opioid treatment consultations. This feedback loop maintains regulatory compliance while enabling remote service delivery.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables efficient and secure remote approval and dispensing of opioid treatment medication to patients in underserved and remote areas, reducing travel requirements and ensuring proper medical oversight.

Implementation Method 1

determining an identity of the patient, by a biometric sensing component

Methodology Applied
Scientific EffectBiometric sensing:

Data Source

PatentUS20250391536A1Remote approval, dispensing, and review of opioid treatment doses
Publication Date: 2025.12.25 OPIO CONNECT INC
  • US20250391536A1 patent drawing
  • US20250391536A1 patent drawing
  • US20250391536A1 patent drawing

AI summary

A method for remotely approving and dispensing medications directly to a patient for opioid addiction treatment. The method includes determining an identity of the patient, by a biometric sensing component and establishing remote communication between the patient and a medical official certified for treating opioid addiction. The method also includes transmitting a medical record corresponding to the patient to the medical official, generating, by the medical official, the opioid addiction treatment, generating an event record made up of the identity of the patient, the opioid addiction treatment, the medical record, and the medical official, and transmitting the event record to a dosing location.